South Africa Halts J&J Vaccine Jabs; Europe Rollout Delayed

South Africa Halts J&J Vaccine Jabs; Europe Rollout Delayed
A box of Janssen vaccines is shown by pharmacist Zsolt Szenasi at a warehouse of Hungaropharma, a Hungarian pharmaceutical wholesale company, in Budapest, Hungary, after the arrival of the first batch of the Johnson & Johnson, US, made one-dose vaccine against the new coronavirus in the country, on April 13, 2021. Szilard Koszticsak/MTI via AP
|Updated:

JOHANNESBURG—South Africa suspended giving Johnson & Johnson vaccine shots Tuesday as a “precautionary measure” and the company delayed its European vaccine rollout following an FDA decision to pause the jabs while very rare blood clot cases are examined.

South Africa has given more than 289,000 doses of the J&J vaccine to the country’s health workers without any reports of rare blood clots, Health Minister Dr. Zweli Mkhize told reporters.